-
CAPTURING THE PATIENT PERSPECTIVE: TARGETED LITERATURE REVIEW FINDINGS ON THE CRITICAL ROLE OF PROS IN ONCOLOGIC AMNOG EVALUATIONS
Aug 11, 2026, 17:16 PM -
IMPACT OF THE 2026 UK EQ-5D-5L VALUE SET ON UTILITY ESTIMATES IN LUPUS RASH AND CUTANEOUS LUPUS ERYTHEMATOSUS
Aug 11, 2026, 17:16 PM -
HOW CTDNA AND UTDNA ARE RESHAPING TREATMENT PATHWAYS IN BLADDER CANCER: IMPLICATIONS FOR EARLY ACCESS, HEALTH TECHNOLOGY ASSESSMENT (HTA) AND REIMBURSEMENT
Aug 11, 2026, 17:16 PM -
THE IMPACT ON NHS CAPACITY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS ISATUXIMAB IN THE UK
Aug 11, 2026, 17:16 PM -
A DECADE OF THE RECOVERING QUALITY OF LIFE (REQOL) QUESTIONNAIRE: UPTAKE AND USE OF A RECOVERY-ORIENTED QUALITY OF LIFE MEASURE IN MENTAL HEALTH CLINICAL RESEARCH
Aug 11, 2026, 17:16 PM -
APPLYING TARGET TRIAL EMULATION TO MULTIDRUG-RESISTANT GRAM-NEGATIVE INFECTIONS IN THE INTENSIVE CARE UNIT: A PRACTICAL FRAMEWORK
Aug 11, 2026, 17:16 PM -
SYSTEMATIC LITERATURE REVIEW OF THE ECONOMIC BURDEN OF TYPE 2 DIABETES IN ITALY: COST DRIVERS ACROSS TREATMENT-DEFINED POPULATIONS
Aug 11, 2026, 17:16 PM -
STRATEGIC RESOURCE ALLOCATION IN IMMUNO-ONCOLOGY: BALANCING ECONOMIC AND ORGANIZATIONAL IMPACT WITHIN THE ITALIAN NHS
Aug 11, 2026, 17:16 PM -
VIDEO GROUP CONSULTATIONS IN GENERAL PRACTICE: TOGETHER 2 EARLY ECONOMIC EVALUATION
Aug 11, 2026, 17:16 PM -
TRANSFORMING PRE-LAUNCH FORECASTING: AN AGENTIC AI PLATFORM FOR TRANSPARENT SCENARIO PLANNING IN PHARMA
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS FROM PAYER PERSPECTIVE. A REAL-WORLD PATIENT-LEVEL MICRO-COSTING STUDY FROM QATAR
Aug 11, 2026, 17:16 PM -
AN AGENTIC AI MODEL VALIDATOR FOR AUTOMATED QUALITY CHECK OF EXCEL-BASED BUDGET IMPACT MODELS
Aug 11, 2026, 17:16 PM -
ARTIFICIAL INTELLIGENCE IN HEALTH TECHNOLOGY ASSESSMENT: A LANDSCAPE REVIEW OF OPPORTUNITIES, CHALLENGES, AND STAKEHOLDER RESPONSIBILITIES
Aug 11, 2026, 17:16 PM -
PRODUCTIVITY LOSS IN PATIENTS WITH MODERATE-TO-SEVERE THYROID EYE DISEASE IN SPAIN AND ITALY: RESULTS FROM A REAL-WORLD CROSS-SECTIONAL STUDY
Aug 11, 2026, 17:16 PM -
ARE AI-BASED DIGITAL TWINS ENTERING HTA? A REVIEW AND INSIGHT INTO AN EMERGING AND EVOLVING EVIDENCE-GENERATION APPROACH
Aug 11, 2026, 17:16 PM -
RANKING OF TREATMENTS IN MULTI-LEVEL NETWORK META-REGRESSION (ML-NMR): INCORPORATING MINIMALLY IMPORTANT DIFFERENCES
Aug 11, 2026, 17:16 PM -
RELAPSE AND ASSOCIATED HEALTHCARE BURDEN IN POLYMYALGIA RHEUMATICA (PMR) AND GIANT CELL ARTERITIS (GCA): A RETROSPECTIVE COHORT STUDY IN GERMANY
Aug 11, 2026, 17:16 PM -
IMPACT OF ENDPOINT SELECTION ON COMPARATIVE EFFICACY CONCLUSIONS IN CROHN'S DISEASE (CD)
Aug 11, 2026, 17:16 PM -
SYSTEMATIC VERSUS ETIOLOGY-RESTRICTED FABRY DISEASE SCREENING IN MOROCCO'S DIALYSIS POPULATION: A DECISION-TREE COST-UTILITY ANALYSIS BENCHMARKED ON A DIALYSIS-REVEALED THRESHOLD
Aug 11, 2026, 17:16 PM -
TRENDS IN THE NUMBER OF HOSPITAL BEDS AND PATIENT TURNOVER IN CARDIOLOGY IN HUNGARY BETWEEN 2014 AND 2024
Aug 11, 2026, 17:16 PM
